Intratumoral patterns of genomic imbalance in glioblastomas

Brain Pathology

Volumn 20, Issue 5, 2010, Pages 936-944

  Nobusawa, Sumihito ^a   Lachuer, Joel ^b   Wierinckx, Anne ^b   Kim, Young Ho ^a   Huang, Jian ^a   Legras, Catherine ^b,c,d   Kleihues, Paul ^e   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ProfileXpert   (Romania)

^c UNIVERSITÉ DE LYON   (France)

^d UMR 754   (France)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

array CGH; glioblastoma; intratumoral heterogeneity; whole genome amplification

Indexed keywords

PARAFFIN;

ARTICLE; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 7P; COMPARATIVE GENOMIC HYBRIDIZATION; GENE AMPLIFICATION; GENOMIC INSTABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATION; PATHOGENESIS;

EID: 77955167915     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00395.x     Document Type: Article

References (31)

1. Burger PC, Pearl DK, Aldape K, Yates AJ, Scheithauer BW, Passe SM et al (2001) Small cell architecture - a histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol 60 : 1099 1104.
2. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 : 1061 1068.
3. Cheung VG, Nelson SF (1996) Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA. Proc Natl Acad Sci U S A 93 : 14676 14679.
4. Daigo Y, Chin SF, Gorringe KL, Bobrow LG, Ponder BA, Pharoah PD, Caldas C (2001) Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue. Am J Pathol 158 : 1623 1631.
5. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60 : 167 179.
6. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG et al (2000) Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 60 : 5405 5409.
7. Greenman C, Wooster R, Futreal PA, Stratton MR, Easton DF (2006) Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173 : 2187 2198.
8. Harada K, Nishizaki T, Ozaki S, Kubota H, Ito H, Sasaki K (1998) Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res 58 : 4694 4700.
9. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65 : 846 854.
10. Huang J, Pang J, Watanabe T, Ng HK, Ohgaki H (2009) Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. J Mol Diagn 11 : 109 116.
11. Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN (2005) Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207 : 224 231.
12. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 : 1801 1806.
13. Jung V, Romeike BF, Henn W, Feiden W, Moringlane JR, Zang KD, Urbschat S (1999) Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58 : 993 999.
14. Lee HG, Petersen RB, Zhu X, Honda K, Aliev G, Smith MA, Perry G (2003) Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathol 13 : 630 638.
15. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System. IARC : Lyon.
16. Misra A, Chattopadhyay P, Dinda AK, Sarkar C, Mahapatra AK, Hasnain SE, Sinha S (2000) Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations. J Neurooncol 48 : 1 12.
17. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K (2001) Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158 : 1253 1262.
18. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15 : 6002 6007.
19. Ohgaki H, Kleihues P (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100 : 2235 2241.
20. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL et al (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64 : 6892 6899.
21. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9 : 667 676.
22. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807 1812.
23. Perry A, Aldape KD, George DH, Burger PC (2004) Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer 101 : 2318 2326.
24. Pinard R, de Winter A, Sarkis GJ, Gerstein MB, Tartaro KR, Plant RN et al (2006) Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing. BMC Genomics 7 : 216.
25. Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD, Maity A (2006) Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol Cancer Res 4 : 471 479.
26. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A (1996) Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 92 : 70 74.
27. Sasaki T, Arai H, Beppu T, Ogasawara K (2003) Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300). Brain Tumor Pathol 20 : 59 63.
28. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314 : 268 274.
29. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y et al (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57 : 684 689.
30. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174 : 1149 1153.
31. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al (2007) The genomic landscapes of human breast and colorectal cancers. Science 318 : 1108 1113.